Healthcare platform Lavita AI has raised $5 million in a seed funding round led by Camford Capital, with participation from angel investors in the AI and blockchain sectors.
The funds will be used to accelerate the development of Lavita’s AI-based platform and related applications for patients, healthcare providers, and research organisations.
The decentralised platform provides a privacy-preserving infrastructure to securely share and analyse health data. It also enables individuals to take ownership, control, and value of their health data. The Lavita platform can be used for numerous applications within life science research, biopharma development, and healthcare innovation.
Patients and individuals can use Lavita to identify and match with clinical trials globally. Life science researchers can use the platform to conduct large-scale population studies such as genome-wide and phenome-wide association studies. Biopharma companies can securely share data across multiple parties for drug discovery or development partnerships. Health institutions can train and fine-tune their own large language models (LLMs) for domain-specific use cases.
Ali Farahanchi, co-founder and head of business and operations at Lavita AI, said that the financing round, together with Lavita’s integration with Theta, a leading provider of Web3 infrastructure, would enable the release of the first decentralised peer-to-peer marketplace for health data.
Health data owners such as patients, health networks, and research centres will be able to share data securely to accelerate the development of new treatments for patients.
Lavita’s partnership with Theta Network will allow individuals to earn LAVITA tokens that can be used to access services from participating healthcare institutions.
These tokens can also be used to participate in Theta Edge Network, a decentralised Web3 infrastructure providing distributed computation and storage for training and fine-tuning healthcare AI models.
Mitchell Liu, co-founder and CEO, Theta Labs, said that Lavita AI is the first company to offer practical means for patients to own their digital health assets and information, providing both control and monetisation without third-party data brokers